Menu

• Ask a Health Expert about ASPARTATE AMINOTRANSFERASE DECREASED
• Post Your Side Effect related to ASPARTATE AMINOTRANSFERASE DECREASED
• ASPARTATE AMINOTRANSFERASE DECREASED and FDA Warnings
• ASPARTATE AMINOTRANSFERASE DECREASED in Patients Wiki
• Report ASPARTATE AMINOTRANSFERASE DECREASED in Drug Side Effect Survey

ASPARTATE AMINOTRANSFERASE DECREASED side effect

What is ASPARTATE AMINOTRANSFERASE DECREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Trisenox Side Effects Report #5556932-4
Physician from JAPAN reported TRISENOX problem on Nov 26, 2007. Female patient, 38 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with TRISENOX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase decreased, blood magnesium decreased, blood potassium decreased, electrocardiogram qt prolonged, gamma-glutamyltransferase increased, hepatic function abnormal, oedema, rash, . TRISENOX dosage: 8.55 MG QD; INTRAVENOUS DRIP. During the same period patient was treated with GLYCYRRHIZIN, MAGNESIUM REPLACEMENT, POTASSIUM REPLACEMENT, HYDROCORTISONE SUCCINATE, PREDNISOLONE, SPIRONOLACTONE, FUROSEMIDE. Patient recovered.

Fluorouracil Side Effects Report #5526062-6
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2007. Male patient, weighting 115.0 lb, was diagnosed with colorectal cancer metastatic and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase decreased, aspartate aminotransferase decreased, blood albumin decreased, blood calcium decreased, blood chloride increased, blood creatinine increased, blood magnesium decreased, blood potassium decreased, blood pressure systolic decreased, . FLUOROURACIL dosage: unknown. During the same period patient was treated with IRINOTECAN, CALCIUM FOLINATE, CAPECITABINE, VICODIN, DOXAZOSIN MESYLATE, FUROSEMIDE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.

Paclitaxel Side Effects Report #5490454-4
Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on Oct 17, 2007. Female patient, weighting 165.3 lb, was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase decreased, blood alkaline phosphatase increased, blood glucose increased, blood sodium decreased, disease progression, fatigue, haematocrit decreased, haemoglobin decreased, . PACLITAXEL dosage: 582 MG. Patient was hospitalized. Patient recovered.

Temodar Side Effects Report #5738666-6
TEMODAR problem was reported by a Physician from UNITED STATES on May 08, 2008. Female patient, weighting 207.5 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase decreased, aspartate aminotransferase decreased, cerebellar haematoma, encephalitic infection, haemoglobin decreased, hypocalcaemia, hypokalaemia, hyponatraemia, lymphopenia, . TEMODAR dosage: unknown. During the same period patient was treated with ACYCLOVIR, CEFTRIAXONE, COLACE, KYTRIL, LOVENOX, PHENYTOIN, PROCHLORPERAZINE, ROLAIDS. Patient was hospitalized. Patient died on 04/14/2008.


Temodar Side Effects Report #5722490-4
Physician from UNITED STATES reported TEMODAR problem on Apr 16, 2008. Female patient, weighting 207.5 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase decreased, aspartate aminotransferase decreased, central nervous system infection, haematoma, haemoglobin decreased, hypocalcaemia, hyponatraemia, lymphopenia, wound dehiscence, . TEMODAR dosage: unknown. During the same period patient was treated with ACYCLOVIR, CEFTRIAXONE, COLACE, KYTRIL, LOVENOX, PHENYTOIN, PROCHLORPERAZINE, ROLAIDS. Patient was hospitalized. Patient died on 04/14/2008.

Irinotecan Side Effects Report #5683261-0
IRINOTECAN problem was reported by a Consumer or non-health professional from JAPAN on Mar 12, 2008. Male patient, weighting 116.8 lb, was diagnosed with non-small cell lung cancer, hypertension, diarrhoea and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase decreased, anorexia, aspartate aminotransferase decreased, blood potassium decreased, blood sodium decreased, interstitial lung disease, pneumonitis, . IRINOTECAN dosage: DAILY DOSE:151MG-FREQ:INTERVAL: DAYS 1,8 EVERY 3 WEEKS. During the same period patient was treated with FRANDOL, URSO, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.